Intensity Modulated Radiation Therapy Market Analysis

Intensity Modulated Radiation Therapy Market Analysis

To get key market trends

  Download Free Sample

The market by radiation type is categorized into proton, electron, photon, and carbon-ion radiation. The proton radiation therapy segment garnered USD 420 million revenue size in the year 2022.

• Proton therapy offers several advantages, its use is often considered in specific clinical scenarios, and the choice of treatment modality depends on factors such as the type and location of tumor, patient's overall health, and the treatment goal.
   
• Ongoing advancements in proton therapy including pencil beam scanning and intensity-modulated proton therapy (IMPT), contribute to improved treatment precision and the ability to deliver highly conformal doses of radiation.
   

Thus, increasing adoption of proton therapy, and rising healthcare expenditure contribute to market expansion.
 

Based on application, the intensity modulated radiation therapy market is segmented into cancer types including prostate, lung, breast, brain, gynecological coupled with other applications. The breast cancer segment dominated the market and accounted for over 26% business share in the year 2022.
 

• The growth can be attributed to the increasing prevalence of breast cancer. For instance, according to the American Cancer Society, in 2023, 297,790 new cases of breast cancer were estimated to be diagnosed, and around 43,700 related deaths are expected to occur in the U.S. alone.
   
• Moreover, as per the WHO, in 2021, breast cancer was the most common type of cancer at a global level, with new cases surpassing 2.3 million. Such high prevalence rate of the disease is expected to bolster segment development.
   

Based on end-use, the intensity modulated radiation therapy market is segmented into hospitals, and standalone radiation therapy centers. The hospitals segment dominated the by accounting for over 52% business share in the year 2022.
 

• The growth is attributable to the availability of emergency facilities, well established healthcare infrastructure and presence of skilled healthcare professionals. Increasing number of patient visits to hospitals for effective treatment and better facilities will result in higher segment progression.
   
• Hospitals are equipped with highly advanced technological products and serve as a base for most of the surgeries carried out worldwide, thus improving patient outcomes and favoring market expansion.
   

U.S. intensity modulated radiation therapy market accounted for over USD 766 million revenue size in 2022 and is predicted to witness substantial market growth over the analysis timeline.
 

• The rising incidence of cancer in the U.S. contributes to the increased demand for advanced and effective cancer treatment modalities.
   
• Additionally, the availability of advanced healthcare facilities, including those equipped with state-of-the-art radiation therapy equipment, influences the adoption of IMRT. Major medical centers and cancer treatment facilities in the U.S. are more likely to offer advanced treatment options such as intensity modulated radiation therapy.
   

Moreover, presence of several market participants focusing on developing innovative products for better patient management will prove advantageous for the market expansion.